Abstract
Mutations at CpG dinucleotides were delineated in the factor IX gene of 38 hemophilia B patients. When transitions at CpG were considered with those previously reported by us and those compiled in the factor IX mutation database, the following patterns emerged. Many CpG sites were mutated with high frequency, while two CpG sites were infrequently mutated (R29→Q and R116→ TGA). Of the 6 possible nonsense mutations and the 14 missense mutations that would produce a nonconservative change at conserved amino acids, all have been observed to cause hemophilia B except A−10→T and R338→Q. By contrast, none of the 6 missense changes at nonconserved amino acids have been observed to cause hemophilia B. At those CpG sites that are frequently mutated, the rate of transitions is estimated to be 20-fold higher than transitions at non-CpG sites. Point mutations in close proximity to CpG dinucleotides did not seem elevated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bottema CDK, Ketterling RP, Yoon H-S, Sommer SS (1990a) The pattern of factor IX germline mutation in Asians is similar to that of Caucasians. Am J Hum Genet 47:835–841
Bottema CDK, Koeberl DD, Ketterling RP, Bowie EJW, Taylor SAM, Bridge PJ, Lillicrap D, Shapiro A, Gilchrist G, Sommer SS (1990b) A past mutation at isoleucine397 is now a common cause of moderate/mild haemophilia B. Br J Haematol 75:212–216
Bottema CDK, Bottema MJ, Ketterling RP, Yoon H-S, Janco RL, Phillips JA, III, Sommer SS (1991a) Why does the human factor IX gene have a G + C content of 40%? Am J Hum Genet 49:839–850
Bottema CDK, Ketterling RP, Ii S, Yoon H-S, Phillips JA, III, Sommer SS (1991b) Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as “spacer” elements. Am J Hum Genet 49:820–838
Brown TC, Jiricny J (1988) Different base/base mispairs are corrected with different efficiencies and specificities in monkey kidney cells. Cell 54:705–711
Camerino G, Grzeschik KH, Jaye M, DeLaSalle H, Tolstoshev P, Lecocq JP, Heilig R, Mandel JL (1984) Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus). Proc Natl Acad Sci USA 81:498–502
Coulondre C, Miller JH, Farabaugh PJ, Gilbert W (1978) Molecular basis of base substitution hotspots in E. coli. Nature 274:775–780
Crossley M, Winship PR, Austen DEG, Rizza CR, Brownlee GG (1990) A less severe form of haemophilia B Leyden. Nucleic Acids Res 18:4633
Diem K, Lentner C (1970) Scientific tables, 7th edn. Ciba-Geigy, Basle, pp 85–103
Dutton C, Sommer SS (1991) Simultaneous detection of multiple single-base alleles at a polymorphic site. BioTechniques 11:700–702
Dutton C, Bottema CDK, Sommer SS (1993) Alu repeats in the human factor IX gene: the rate of polymorphism is not substantially elevated. Hum Mutat (in press)
Eyster ME, Lewis JH, Shapiro SS, Gill F, Kajani M, Prager D, Djerassi I, Rice S, Lusch C, Keller A (1980) The Pennsylvania hemophilia program 1973–1978. Am J Hematol 9:277–286
Friedberg EC (ed) (1985) DNA repair. Freeman, San Francisco, pp 284–286
Furie B, Furie BC (1988) The molecular basis of blood coagulation. Cell 53:505–518
Giannelli F, Green PM, High KA, Sommer S, Lillicrap DP, Ludwig M, Olek K, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG (1991) Haemophilia B: database of point mutations and short additions and deletions, 2nd edn. Nucleic Acids Res 19:2193–2219
Green PM, Bentley DR, Mibashan RS, Nillson IM, Giannelli F (1989) Molecular pathology of haemophilia B. EMBO J 8:1067–1072
Green PM, Montandon AJ, Bentley DR, Ljung R, Nilsson IM, Giannelli F (1990) The incidence and distribution of CpG→TpG transitions in the coagulation factor IX gene. Nucleic Acids Res 18:3227–3231
Gustafson S, Proper JA, Bowie EJW, Sommer SS (1987) Parameters affecting the yield of DNA from human blood. Anal Biochem 165:294–299
Hirosawa S, Fahner JB, Salier J-P, Wu C-T, Lovrien EW, Kurachi K (1990) Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden. Proc Natl Acad Sci USA 87:4421–4425
Jorgensen MJ, Cantor AB, Furie BC, Brown CL, Shoemaker CB, Furie B (1987) Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX. Cell 48:185–191
Ketterling RP, Bottema CDK, Koeberl DD, li S, Sommer SS (1991a) T296→M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays, and rapid carrier detection. Hum Genet 87:333–337
Ketterling RP, Bottema CDK, Phillips JP, III, Sommer SS (1991b) Evidence that descendants of three founders comprise about 25% of hemophilia B in the United States. Genomics 10:1093–1096
Koeberl DD, Bottema CDK, Buerstedde J, Sommer SS (1989) Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG. Am J Hum Genet 45:448–457
Koeberl DD, Bottema CDK, Ketterling RP, Bridge PJ, Lillicrap DP, Sommer SS (1990) Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in the human gene. Am J Hum Genet 47:202–217
Larsson SA, Nilsson IM, Blomback M (1982) Current status of Swedish hemophiliacs. Acta Med Scand 212:195–200
Lieb M (1983) Specific mismatch correction in bacteriophage lambda crosses by very short-patch repair. Mol Gen Genet 191:118–125
Lieb M (1985) Recombination in the lambda repressor gene: evidence that very short-patch (VSP) mismatch correction restores a specific sequence. Mol Gen Genet 199:465–470
Sarkar G, Paynton C, Sommer SS (1991) Segments containing alternating purine and pyrimidine dinucleotides: patterns of polymorphism in humans and prevalence throughout phylogeny. Nucleic Acids Res 19:631–636
Sommer SS (1990) Mutagen test. Nature 346:22–23
Sommer SS, Sarkar G, Koeberl DD, Bottema CDK, Buerstedde J-M, Schowalter DB, Cassady JD (1990) Direct sequencing with the aid of phage promoters. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols: a guide to methods and applications. Academic Press, New York, pp 197–205
Sommer SS, Bowie EJW, Ketterling RP, Bottema CDK (1992) Missense mutations and the magnitude of functional deficit: the example of factor IX. Hum Genet 89:295–297
Stoflet ES, Koeberl DD, Sarkar G, Sommer SS (1988) Genomic amplification with transcript sequencing. Science 239:491–494
Thompson AR, Bajaj SP, Chen S-H, MacGillivray RTA (1990) “Founder” effect in different families with haemophilia B mutation. Lancet 1:418
Wiebauer K, Jiricny J (1990) Mismatch-specific thymine DNA glycosylase and DNA polymerase beta mediate the correction of GT mispairs in nuclear extracts from human cells. Proc Natl Acad Sci USA 87:5842–5845
Winship PR, Anson DS, Rizza CR, Brownlee GG (1984) Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. Nucleic Acids Res 12:8861–8872
Winship PR, Rees DJG, Alkan M (1989) Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers. Lancet 1:631–634
Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K (1985) Nucleotide sequence of the gene for human factor IX (antihemophiliac factor B). Biochemistry 24:3736–3750
Zhang M, Chen S-H, Scott CR, Thompson AR (1989) The factor IX BamHI polymorphism: T-to-G transversion at the nucleotide sequence -561. Hum Genet 82:283–284
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bottema, C.D.K., Ketterling, R.P., Vielhaber, E. et al. The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene. Hum Genet 91, 496–503 (1993). https://doi.org/10.1007/BF00217779
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00217779